Skip Navigation

Cardiovascular Research 1998 40(1):182-190; doi:10.1016/S0008-6363(98)00113-8
© 1998 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Eskildsen-Helmond, Y. E.G.
Right arrow Articles by Lamers, J. M.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eskildsen-Helmond, Y. E.G.
Right arrow Articles by Lamers, J. M.J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1998, European Society of Cardiology

Phospholipid source and molecular species composition of 1,2-diacylglycerol in agonist-stimulated rat cardiomyocytes

Yvonne E.G. Eskildsen-Helmonda, Daniela Hahnelb, Ulrike Reinhardtb, Dick H.W. Dekkersa, Bernd Engelmannb and Jos M.J. Lamersa,*

aDepartment of Biochemistry, Cardiovascular Research Institute COEUR, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam, P.O.Box 1738, 3000 DR Rotterdam, The Netherlands
bPhysiologisches Institut der Universität München, Pettenkoferstrasse 12, 80336 München, Germany

* Corresponding author. Tel: +31 (10) 408 7335; Fax: +31 (10) 436 0615; E-mail: lamers@bc1.fgg.eur.nl

Objective: The aim was to investigate the consequences of simultaneous stimulation of phospholipase C and D by agonists for the molecular species composition of 1,2-diacylglycerol and phospholipids in cardiomyocytes. Methods: Serum-free cultured neonatal rat cardiomyocytes were stimulated by endothelin-1, phenylephrine or phorbolester. The molecular species of 1,2-diacylglycerol (in mol%) and those derived from phosphatidylcholine and phosphatidylinositol were analyzed by high-performance liquid chromatography and their absolute total concentration (nmol per dish) by gas–liquid chromatography. Phospholipids were labelled with [14C]glycerol or double-labelled with [14C]16:0 and [3H]20:4n6 for measurements of respectively, the amount of or relative rate of label incorporation into 1,2-diacylglycerol. Results: The major molecular species of 1,2-diacylglycerol in unstimulated cells was found to be 18:0/20:4 (57 mol%). The same species was observed predominantly in phosphatidylinositol (73 mol% compared to 11 mol% in phosphatidylcholine). A significant decrease (about 10 mol%) was found for the 18:0/20:4 species of 1,2-diacylglycerol during stimulation (10–40 min) with endothelin-1 or phorbolester, but not phenylephrine. The results of the double-labelling experiments were consistent with the latter finding: the ratio [3H]20:4 over [14C]16:0 in 1,2-diacylglycerol decreased from 1.70 in the control to 1.40 during 10-min endothelin-1 or phorbolester stimulation, but not during phenylephrine stimulation. The [14C]glycerol incorporation into 1,2-diacylglycerol remained relatively constant under agonist-stimulated conditions as did the total concentration of 1,2-diacylglycerol. Conclusions: 1,2-Diacylglycerol present in unstimulated cardiomyocytes is likely derived from phosphatidylinositol. During stimulation with endothelin-1 and phorbolester, but not phenylephrine, phosphatidylcholine becomes an increasingly important source for 1,2-diacylglycerol due to sustained activation of phospholipase D. The 1,2-diacylglycerol level remains relatively constant during agonist stimulation which strongly indicates that particular molecular species of 1,2-diacylglycerol more than its total concentration determine the activation of protein kinase C isoenzymes.

KEYWORDS ET-1, endothelin-1; PMA, phorbol 12-myristate 13-acetate; PHE, phenylephrine; AngII, angiotensin II; PtdIns(4,5)P2, phosphatidylinositol-4,5-bisphosphate; Ins(1,4,5)P3, inositol-1,4,5-trisphosphate; 1,2-DAG, 1,2-diacylglycerol; TAG, triacylglycerol; PKC, protein kinase C; PLC, PLD and PLA2, respectively phospholipase C, D and A2; PtdChol, PtdIns, PtdEtn, PtdSer, respectively phosphatidylcholine, -inositol, -ethanolamine, -serine; (HP)TLC, (High-performance) thin-layer chromatography; HPLC and GLC, respectively, high-performance and gas–liquid chromatography; DPH, diphenyl-1,3,5 hexatrien; DNBC, 3,5-dinitrobenzoylchloride; stearic acid, 18:0; arachidonic acid, 20:4n6; palmitic acid, 16:0.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Exp. Biol. Med.Home page
M. Hlavackova, J. Neckar, J. Jezkova, P. Balkova, B. Stankova, O. Novakova, F. Kolar, and F. Novak
Dietary Polyunsaturated Fatty Acids Alter Myocardial Protein Kinase C Expression and Affect Cardioprotection Induced by Chronic Hypoxia
Experimental Biology and Medicine, June 1, 2007; 232(6): 823 - 832.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
T. Asai, K. Okumura, R. Takahashi, H. Matsui, Y. Numaguchi, H. Murakami, R. Murakami, and T. Murohara
Combined therapy with PPAR{alpha} agonist and L-carnitine rescues lipotoxic cardiomyopathy due to systemic carnitine deficiency
Cardiovasc Res, June 1, 2006; 70(3): 566 - 577.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
R. Takahashi, K. Okumura, T. Asai, T. Hirai, H. Murakami, R. Murakami, Y. Numaguchi, H. Matsui, M. Ito, and T. Murohara
Dietary fish oil attenuates cardiac hypertrophy in lipotoxic cardiomyopathy due to systemic carnitine deficiency
Cardiovasc Res, November 1, 2005; 68(2): 213 - 223.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
R. Takahashi, K. Okumura, H. Matsui, Y. Saburi, H. Kamiya, K. Matsubara, T. Asai, M. Ito, and T. Murohara
Impact of {alpha}-tocopherol on cardiac hypertrophy due to energy metabolism disorder: the involvement of 1,2-diacylglycerol
Cardiovasc Res, June 1, 2003; 58(3): 565 - 574.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
Y. Saburi, K. Okumura, H. Matsui, K. Hayashi, H. Kamiya, R. Takahashi, K. Matsubara, and M. Ito
Changes in distinct species of 1,2-diacylglycerol in cardiac hypertrophy due to energy metabolic disorder
Cardiovasc Res, January 1, 2003; 57(1): 92 - 100.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
J. C. Lenz, H. P. Reusch, N. Albrecht, G. Schultz, and M. Schaefer
Ca2+-controlled competitive diacylglycerol binding of protein kinase C isoenzymes in living cells
J. Cell Biol., October 28, 2002; 159(2): 291 - 302.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.